Sign in

CIK 0000818686 · Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972 (3) 914-8213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,242,786
in 10 filings, $10.6M under 10b5-1 plans

Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-02-28 Drape Eric Executive VP Global Operations Option exercise · Restricted Share Units −19,514 19,515
2023-02-28 Drape Eric Executive VP Global Operations Option exercise · Restricted Share Units −47,598 0
2023-02-28 Dethlefs Sven EVP, North America Commercial Option exercise +17,346 182,727
2023-02-28 Dethlefs Sven EVP, North America Commercial Sale −17,346 $9.89 $171K 165,381
2023-02-28 Dethlefs Sven EVP, North America Commercial Option exercise +42,309 207,690
2023-02-28 Dethlefs Sven EVP, North America Commercial Sale −42,309 $9.89 $418K 165,381
2023-02-28 Dethlefs Sven EVP, North America Commercial Option exercise · Restricted Share Units −17,346 17,346
2023-02-28 Dethlefs Sven EVP, North America Commercial Option exercise · Restricted Share Units −42,309 0
2023-02-28 Daniell Richard Exec. VP, European Commercial Option exercise +20,598 63,780
2023-02-28 Daniell Richard Exec. VP, European Commercial Sale −20,598 $9.89 $204K 43,182
2023-02-28 Daniell Richard Exec. VP, European Commercial Option exercise +50,242 93,424
2023-02-28 Daniell Richard Exec. VP, European Commercial Sale −23,654 $9.89 $234K 69,770
2023-02-28 Daniell Richard Exec. VP, European Commercial Option exercise · Restricted Share Units −20,598 20,599
2023-02-28 Daniell Richard Exec. VP, European Commercial Option exercise · Restricted Share Units −50,242 0
2023-02-15 Francis Richard D President and CEO Grant or award · Restricted Share Units +484,966 484,966
2023-02-13 Kalif Eliyahu Sharon EVP, Chief Financial Officer Option exercise +6,629 16,005
2023-02-13 Kalif Eliyahu Sharon EVP, Chief Financial Officer Option exercise · Restricted Share Units −6,629 6,630
2023-02-07 Stark David Matthew Exec. VP Chief Legal Officer Grant or award · Restricted Share Units +44,953 44,953
2023-02-07 Sabag Mark EVP, International Markets Grant or award · Restricted Share Units +50,242 50,242
2023-02-07 Kalif Eliyahu Sharon EVP, Chief Financial Officer Grant or award · Restricted Share Units +44,953 44,953

Page 33 of 76 · 1,517 trades